It takes 2 antioxidants to tango: the interaction between manganese superoxide dismutase and glutathione peroxidase-1

Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism. Accumulation of ROS without an effective antioxidant response can lead to oxidative stress, resulting in macromolecular damage that is implicated in the etiology of various diseases including cancer. ROS detoxification is regulated by various antioxidant proteins, specifically manganese superoxide dismutase (MnSOD), which catalyzes the conversion of superoxide into H2O2, and the subsequent conversion of H2O2 into water is catalyzed by glutathione peroxidase 1 (GPx-1). In vitro and in vivo evidence supports a conflicting role of MnSOD in tumor biology and indicates that an interaction between MnSOD and GPx-1 can modulate the impact of MnSOD on carcinogenesis. Additional support for this idea is provided by epidemiological data indicating that an association exists between polymorphisms in the MnSOD and GPx-1 genes and cancer risk, such that individuals who carry both at-risk polymorphisms are at a higher risk of several types of cancer. Future studies examining the impact of these 2 antioxidants on tumor biology need to consider the interplay between the 2 genes.

Anahtar Kelimeler:

Oxidative stress, cancer, manganese superoxide dismutase, selenium, glutathione peroxidase

It takes 2 antioxidants to tango: the interaction between manganese superoxide dismutase and glutathione peroxidase-1

Keywords:

Oxidative stress, cancer, manganese superoxide dismutase, selenium, glutathione peroxidase,

PDF

___

Ansenberger-Fricano K, Ganini D, Mao M, Chatterjee S, Dallas S, Mason RP, Stadler K, Santos JH, Bonini MG (2013). The peroxidase activity of mitochondrial superoxide dismutase. Free Radic Biol Med 54: 116–124.
Arthur JR (2000). The glutathione peroxidases. Cell Mol Life Sci 57: 1825–1835.
Asayama K, Yokota S, Dobashi K, Hayashibe H, Kawaoi A, Nakazawa S (1994). Purification and immunoelectron microscopic localization of cellular glutathione peroxidase in rat hepatocytes: quantitative analysis by postembedding method. Histochemistry 102: 213–219.
Berry MJ, Banu L, Chen Y, Mandel SJ, Kiefer JD, Harney JW, Larsen PR (1991). Recognition of UGA as a selenocysteine codon in Type I deiodinase requires sequences in the 3’ untranslated region. Nature 353: 273–276.
Caban K, Copeland PR (2006). Size matters: a view of selenocysteine incorporation from the ribosome. Cell Mol Life Sci 63: 73–81.
Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM (1993). Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A 90: 3113– 3117.
Cooper ML, Adami HO, Gronberg H, Wiklund F, Green FR, Rayman MP (2008). Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 68: 10171–10177.
Cox DG, Hankinson SE, Kraft P, Hunter DJ (2004). No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13: 1821–1822.
Cox DG, Tamimi RM, Hunter DJ (2006). Gene x gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer 6: 217.
Darby-Weydert CJ, Smith BB, Xu L, Kregel KC, Ritchie JM, Davis CS, Oberley LW (2003). Inhibition of oral cancer cell growth by adenovirus MnSOD plus BCNU treatment. Free Radic Biol Med 34: 316–329.
Dhar SK, St Clair DK (2012). Manganese superoxide dismutase regulation and cancer. Free Radic Biol Med 52: 2209–2222.
Finkel T (2011). Signal transduction by reactive oxygen species. J Cell Biol 194: 7–15.
Fridovich I (1975). Superoxide dismutases. Annu Rev Biochem 44: 147–159.
Hatfield DL, Gladyshev VN (2002). How selenium has altered our understanding of the genetic code. Mol Cell Biol 22: 3565– 3576.
Holley AK, Dhar SK, St Clair DK (2013). Curbing cancer’s sweet tooth: is there a role for MnSOD in regulation of the Warburg effect? Mitochondrion 13: 170–188.
Hu YJ, Diamond AM (2003). Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63: 3347–3351.
Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY et al. (2007). Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 16: 1581–1586.
Kato K, Oguri M, Kato N, Hibino T, Yajima K, Yoshida T, Metoki N, Yoshida H, Satoh K, Watanabe S et al. (2008). Assessment of genetic risk factors for thoracic aortic aneurysm in hypertensive patients. Am J Hypertens 21: 1023–1027.
Lei C, Niu X, Wei J, Zhu J, Zhu Y (2009). Interaction of glutathione peroxidase-1 and selenium in endemic dilated cardiomyopathy. Clin Chim Acta 399: 102–108.
Levine A, Tenhaken R, Dixon R, Lamb C (1994). H2O2 from the oxidative burst orchestrates the plant hypersensitive disease resistance response. Cell 79: 583–593.
Li F, Wang H, Huang C, Lin J, Zhu G, Hu R, Feng H (2011). Hydrogen peroxide contributes to the manganese superoxide dismutase promotion of migration and invasion in glioma cells. Free Radic Res 45: 1154–1161.
Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, Ma J (2005). Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65: 2498–2504.
Li S, Yan T, Yang JQ, Oberley TD, Oberley LW (2000). The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927–3939.
Lubos E, Loscalzo J, Handy DE (2011). Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15: 1957–1997.
Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Wu K, Erdman JW Jr, Giovannucci E (2008). Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 29: 2335–2340.
Ming X, Johnson WG, Stenroos ES, Mars A, Lambert GH, Buyske S (2010). Genetic variant of glutathione peroxidase 1 in autism. Brain Dev 32: 105–109.
Mohr A, Buneker C, Gough RP, Zwacka RM (2008). MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. Oncogene 27: 763–774.
Nelson KK, Ranganathan AC, Mansouri J, Rodriguez AM, Providence KM, Rutter JL, Pumiglia K, Bennett JA, Melendez JA (2003). Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 9: 424–432.
Niethammer P, Grabher C, Look AT, Mitchison TJ (2009). A tissue- scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996–999.
Oberley LW, Buettner GR (1979). Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141–1149.
Palazzotti B, Pani G, Colavitti R, De Leo ME, Bedogni B, Borrello S, Galeotti T (1999). Increased growth capacity of cervical- carcinoma cells over-expressing manganous superoxide dismutase. Int J Cancer 82: 145–150.
Pera J, Slowik A, Dziedzic T, Pulyk R, Wloch D, Szczudlik A (2008). Glutathione peroxidase 1 C593T polymorphism is associated with lobar intracerebral hemorrhage. Cerebrovasc Dis 25: 445–449.
Schallreuter KU, Gleason FK, Wood JM (1990). The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta 1054: 14–20.
Solodilova MA, Ivanov VP, Polonikov AV, Khoroshaia IV, Kozhukhov MA, Panfilov VI (2007). Heterozygosity of 198LEU mutant allele in glutathione peroxidase-1 gene as a risk factor of bronchial asthma associated with smoking. Ter Arkh 79: 33–36 (article in Russian with English abstract).
Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, Jansen E, Akesson B, Rohrmann S, Linseisen J (2010). Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 19: 2958–2968.
Sundaresan M, Yu Z, Ferrans VJ, Irani K, Finkel T (1995). Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296–299.
Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, Pessayre D, Degoul F (2005). The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 15: 311–319.
Sutton A, Nahon P, Pessayre D, Rufat P, Poire A, Ziol M, Vidaud D, Barget N, Ganne-Carrie N, Charnaux N et al. (2006). Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res 66: 2844– 2852.
Tang NP, Wang LS, Yang L, Gu HJ, Sun QM, Cong RH, Zhou B, Zhu HJ, Wang B (2008). Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clin Chim Acta 395: 89–93.
Utsunomiya H, Komatsu N, Yoshimura S, Tsutsumi Y, Watanabe K (1991). Exact ultrastructural localization of glutathione peroxidase in normal rat hepatocytes: advantages of microwave fixation. J Histochem Cytochem 39: 1167–1174.
Weerapana E, Wang C, Simon GM, Richter F, Khare S, Dillon MB, Bachovchin DA, Mowen K, Baker D, Cravatt BF (2010). Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468: 790–795.
Weydert CJ, Zhang Y, Sun W, Waugh TA, Teoh ML, Andringa KK, Aykin-Burns N, Spitz DR, Smith BJ, Oberley LW (2008). Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. Free Radic Biol Med 44: 856–867.
Winter JP, Gong Y, Grant PJ, Wild CP (2003). Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease. Coron Artery Dis 14: 149–153.
Zhuo P, Diamond AM (2009). Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 115: 227–242.
Zhuo P, Goldberg M, Herman L, Lee BS, Wang H, Brown RL, Foster CB, Peters U, Diamond AM (2009). Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res 69: 8183–8190.